Avion Wealth’s West Pharmaceutical WST Stock Holding History

Avion Wealth’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4K	Buy	13 +6	+86%	+$1.83K	﹤0.01%	890
2026 Q1	$1K	Sell	7 -4	-36%	-$995	﹤0.01%	1175
2025 Q4	$3K	Hold	11	–	–	﹤0.01%	825
2025 Q3	$2K	Buy	11 +6	+120%	+$1.46K	﹤0.01%	924
2025 Q2	$1K	Sell	5 -8	-62%	-$1.71K	﹤0.01%	1098
2025 Q1	$4K	Hold	13	–	–	﹤0.01%	614
2024 Q4	$4K	Buy	13 +9	+225%	+$2.83K	﹤0.01%	612
2024 Q3	$1K	Sell	4 -2	-33%	-$612	﹤0.01%	929
2024 Q2	$1K	Buy	6 +1	+20%	+$353	﹤0.01%	844
2024 Q1	$2K	Sell	5 -1	-17%	-$370	﹤0.01%	800
2023 Q4	$2K	Sell	6 -4	-40%	-$1.42K	﹤0.01%	641
2023 Q3	$3K	Buy	10 +4	+67%	+$1.55K	﹤0.01%	443
2023 Q2	$1K	Buy	+6	New	+$2.14K	﹤0.01%	669

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Avion Wealth's WST Position: Q2 2026 in Review

Avion Wealth increased its West Pharmaceutical (WST) stake by 86% in Q2 2026, buying an estimated $1.83K and bringing the position to 13 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

Avion Wealth first reported a position in WST in Q2 2023 and has held it in 13 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Avion Wealth held 13 shares of West Pharmaceutical worth $4K as of Q2 2026.
Avion Wealth bought 6 West Pharmaceutical shares in Q2 2026, an estimated $1.83K.
West Pharmaceutical made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #890 holding.
Avion Wealth first reported a position in West Pharmaceutical in Q2 2023 and has held it in 13 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.